James B Weissman - Net Worth and Insider Trading

James B Weissman Net Worth

The estimated net worth of James B Weissman is at least $611,520 dollars as of 2024-04-26. James B Weissman is the COO & EVP of Dicerna Pharmaceuticals Inc and owns about 16,000 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $611,520. Details can be seen in James B Weissman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James B Weissman has not made any transactions after 2021-07-06 and currently still holds the listed stock(s).

Transaction Summary of James B Weissman

To

James B Weissman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James B Weissman owns 1 companies in total, including Dicerna Pharmaceuticals Inc (DRNA) .

Click here to see the complete history of James B Weissman’s form 4 insider trades.

Insider Ownership Summary of James B Weissman

Ticker Comapny Transaction Date Type of Owner
DRNA Dicerna Pharmaceuticals Inc 2021-07-06 Chief Operating Officer & EVP

James B Weissman Latest Holdings Summary

James B Weissman currently owns a total of 1 stock. James B Weissman owns 16,000 shares of Dicerna Pharmaceuticals Inc (DRNA) as of July 6, 2021, with a value of $611,520.

Latest Holdings of James B Weissman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DRNA Dicerna Pharmaceuticals Inc 2021-07-06 16,000 38.22 611,520

Holding Weightings of James B Weissman


James B Weissman Form 4 Trading Tracker

According to the SEC Form 4 filings, James B Weissman has made a total of 21 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Dicerna Pharmaceuticals Inc is the sale of 30,000 shares on July 6, 2021, which brought James B Weissman around $1 Million.

Insider Trading History of James B Weissman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James B Weissman Trading Performance

GuruFocus tracks the stock performance after each of James B Weissman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James B Weissman is 5.83%. GuruFocus also compares James B Weissman's trading performance to market benchmark return within the same time period. The performance of stocks bought by James B Weissman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James B Weissman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James B Weissman

Average Return

-0.31%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.83 5.83 13.5 -0.31 110.82 51.86
Relative Return to S&P 500(%) 4.28 0.02 8.64 -16.14 95.84 40.08

James B Weissman Ownership Network

Ownership Network List of James B Weissman

No Data

Ownership Network Relation of James B Weissman


James B Weissman Owned Company Details

What does Dicerna Pharmaceuticals Inc do?

Who are the key executives at Dicerna Pharmaceuticals Inc?

James B Weissman is the Chief Operating Officer & EVP of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .

Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dicerna Pharmaceuticals Inc Insider Transactions

No Available Data

James B Weissman Mailing Address

Above is the net worth, insider trading, and ownership report for James B Weissman. You might contact James B Weissman via mailing address: C/o Dicerna Pharmaceuticals, Inc. 33 Hayden Avenue Lexington Ma 02421.

Discussions on James B Weissman

No discussions yet.